


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+0.64%
-3.14%
-1.40%
CMND
Clearmind Medicine
$0.07
Strengths

Earnings are forecast to grow
CMND Price Performance
$0.28 (-75.00%)
$1.19 (-94.12%)
$1.03 (-93.20%)
$1.5 (-95.33%)
CMND has High risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Price under $5

High volatilty

CMND overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
CMND Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
CMND Street Sentiment is unimpressive but have positive views on the near-term outlook
Average key support and resistance price levels
Login to displayWhat is CMND current stock price?
What are CMND stock strengths?
What is CMND Risk Level?
What is CMND market cap and volume?
What is CMND current Stock IQ?
Should I buy CMND stock right now?
Is CMND a Strong Buy right now?
What does a 'Strong Buy' rating mean for CMND?
What does a 'Strong Sell' rating mean for CMND?
What factors influence CMND's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+0.64%
-3.14%
-1.40%
CMND
Clearmind Medicine
Current Price
$0.07
Stock Insights
Strengths

Earnings are forecast to grow

CMND Price Performance
$0.28 (-75.00%)
$1.19 (-94.12%)
$1.03 (-93.20%)
$1.5 (-95.33%)
CMND Analysts Opinion
CMND Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
CMND Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
CMND Street Sentiment is unimpressive but have positive views on the near-term outlook
CMND has High risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Price under $5

High volatilty

Average key support and resistance price levels
CMND Stock IQ
CMND Latest Analysis
Clearmind Medicine To Implement 1-for-40 Reverse Stock Split Next Week . (RTTNews) - Clearmind Medicine Inc. (CMND) a clinical-stage biotech company developing psychedelic-derived therapeutics has announced a reverse share split of its issued and outstanding common shares at a ratio of 1-for-40.
Thu Dec 11, 2025
Why Did Clearmind Medicine Shares Plunge 29% After Hours?. CMND) shares fell 29.92% in after-hours trading on Wednesday dropping to $0.0801.Check out the current price of CMND stock here.The stock of the clinical-stage company closed on Wednesday at $0.11 down 6.08% according to Benzinga Pro data.Clearmind Medicine announced on Wednesday that it will implement a 1-for-40 reverse stock split effective Dec. 15.The company stated the reverse split is intended to help it regain compliance with the N
Thu Dec 11, 2025
Clearmind Medicine to enact 1-for-40 reverse share split. shares down.
Wed Dec 10, 2025
Clearmind Medicine stock drops after Nasdaq compliance notice.
Fri Dec 5, 2025
Clearmind Medicine schedules annual and special shareholder meeting for December.
Fri Nov 28, 2025
Why Did Clearmind Medicine Shares Jump 7% In Pre-Market Trading?. CMND) jumped 7.09% in pre-market trading on Wednesday surging to $0.1713.Check out the current price of CMND stock here.According to Benzinga Pro data the stock closed on Tuesday at $0.16 down 19.4%.On Tuesday the company announced Tel Aviv Sourasky Medical Center (TASMC) enrolled the first participant in its multinational Phase I/IIa clinical trial of CMND-100 for alcohol use disorder approved by the United States Food and Drug A
Wed Nov 26, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
CMND Stock trends
CMND Stock performance
CMND Stock analysis
CMND investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.